Dose rate constant of a cesium-131 interstitial brachytherapy seed measured by thermoluminescent dosimetry and gamma-ray spectrometry.
Dose rate constant of a cesium-131 interstitial brachytherapy seed measured by thermoluminescent dosimetry and gamma-ray spectrometry.
复制标题
通过热释光剂量测定法和伽玛射线光谱测定法测量铯 131 间质近距离放射治疗种子的剂量率常数。
DOI:
10.1118/1.2098127
复制
发表时间:
2005
期刊:
影响因子:
3.8
通讯作者:
Nath,R
中科院分区:
文献类型:
--
作者:
Chen,Z;Bongiorni,P;Nath,R
The aim of this work was to conduct an independent determination of the dose rate constant of the newly introduced Model CS‐1 seed. A total of eight seeds were obtained from the seed manufacturer. The air‐kerma strength of each seed was measured by the manufacturer whose calibration is traceable to the air‐kerma strength standard established for the seeds at the National Institute of Standards and Technology ( uncertainty ). The dose rate constant of each seed was measured by two independent methods: One based on the actual photon energy spectrum emitted by the seed using gamma‐ray spectrometry and the other based on the dose‐rate measured by thermoluminescent dosimeter (TLD) in a Solid Water™ phantom. The dose rate constant in water determined by the gamma‐ray spectrometry technique and by the TLD dosimetry are and , respectively, showing excellent agreement with each other. These values, however, are approximately 15% greater than a previously reported value of [Med. Phys. 31, 1529–1538 (2004)]. Although low‐energy fluorescent x rays at 16.6 and 18.7 keV, originating from niobium present in the seed construction, were measured in the energy spectrum of the seeds, their yields were not sufficient to lower the dose rate constant to the value of . Additional determinations of the dose rate constant may be needed to establish an AAPM recommended consensus value for routine clinical use of the seed.